Search results for:
vaccinia immune globulin, human
vaccinia immune globulin, human
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
VIGIV, CNJ-016 |
SOLUTION, INTRAVENOUS |
5% or 50 mg/mL |
|
|
|
|
Last updated: Oct. 10, 2022
Restricted to use by infectious diseases prescribers per CDC guidelines.
Reviewed: Sept. 2022 (VIGIV, CNJ-106)